Shengma Biejia Decoction Inhibits Cell Growth in Multiple Myeloma by Inducing Autophagy-Mediated Apoptosis Through the ERK/mTOR Pathway

• Egile Nagusiak: Huibo Dai (Egilea), Bangyun Ma (Egilea), Xingbin Dai (Egilea), Jie Pang (Egilea), Jingyu Wang (Egilea), Yandong Zhao (Egilea), Mengya Wang (Egilea), Hong Zhang (Egilea), Haoran Gao (Egilea), Shushu Qian (Egilea), Fang Tian (Egilea), Xuemei Sun (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2021-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Shengma Biejia decoction (SMBJD), a traditional Chinese formula recorded in the Golden Chamber, has been widely used for the treatment of malignant tumors. However, its underlying molecular targets and mechanisms are still unclear. This study showed that SMBJD inhibited tumor growth and stimulated h...